OnDemand Webinar: Recent Advances in Amorphous Solid Dispersions
Advances in amorphous solid dispersion (ASD) development are helping to unlock previously undevelopable poorly soluble small molecules and bioavailability challenges. Identifying the appropriate bioavailability enhancement technology in early development is essential to avoiding expensive redevelopment, or worse clinical failure due to lack of exposure. During this workshop, presenters will share insights into recent advancements in amorphous dispersion development and analytical techniques to overcome solubility and scalability challenges, as well as analytical techniques to assess the performance of ASDs.
OnDemand Webinar: Amorphous Solid Dispersions: Development Trends, Challenges and the Future
The pharmaceutical industry is pushing the boundaries of the chemical drug space in search of new and more effective compounds. However, many of these new molecules have properties that make them difficult to develop, including challenging physiochemical characteristics. As a result, the number of poorly soluble drugs in the pipeline is increasing, and there is a growing need for innovation and new technology solutions to produce amorphous solid dispersions.
In this webinar, the featured speaker will explore the latest trends and challenges in the development of poorly soluble molecules. The speaker will also introduce attendees to the KinetiSol Technology — a cutting-edge approach that overcomes the limitations of current amorphous dispersion technologies. This innovative and flexible solution revolutionizes the conventional manufacturing process of amorphous solid dispersions, paving the way for improved drug absorption and dosage forms.
Register for this webinar to learn how this next-generation technology for amorphous solid dispersions can help address the challenges of developing and manufacturing poorly soluble drugs. Learn about the benefits it can provide for the pharmaceutical industry as a whole.